tripotassium citrate (Q22113): Difference between revisions
Jump to navigation
Jump to search
Created claim: medical condition treated (P663): nephrolithiasis (Q22118) |
Changed claim: medical condition treated (P663): nephrolithiasis (Q22118) |
||||||||||||||
| Property / medical condition treated: nephrolithiasis / qualifier | |||||||||||||||
start time: 29 August 1985
| |||||||||||||||
| Property / medical condition treated: nephrolithiasis / qualifier | |||||||||||||||
Revision as of 22:53, 21 April 2024
chemical compound
- Urocit-Kanhydrous potassium citrate
- anhydrous tripotassium citrate
- citric acid tripotassium salt (anhydrous)
- citric acid tripotassium salt (anh.)
- potassium citrate (anh.)
- tripotassium citrate (anhydrous)
- tripotassium citrate (anh.)
- tripotassium cirtate
- potassium citrate anhydrous
- Potassium Citrate
- potassium citrate
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | tripotassium citrate |
chemical compound |
|
Statements
C₆H₅K₃O₇
0 references